The Claim
Adenosine A2A receptors, which are primarily located in striatal neurons in healthy brains, are present in glial cells within the hippocampus and cerebral cortex in individuals with Alzheimer's disease, indicating a pathological redistribution of this receptor subtype.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In Alzheimer's disease, adenosine A2A receptors, normally found in specific brain neurons, are detected in glial cells in the hippocampus and cerebral cortex, showing a change in their location compared to healthy brains.
See the scientific wording
Adenosine A2A receptors, which are primarily located in striatal neurons in healthy brains, are found in glial cells within the hippocampus and cerebral cortex of individuals with Alzheimer's disease, indicating a pathological redistribution of this receptor subtype.
In Alzheimer's disease, adenosine A2A receptors move from their normal location in certain brain cells to different cells called glia in areas affected by the disease, where they become active and contribute to harmful protein buildup and cell damage.
What the research says
1 studyIn healthy brains, a certain brain signal receptor called A2A is mostly in one type of brain cell, but in Alzheimer’s patients, it shows up in different cells called glia in areas damaged by the disease — the study saw this change directly in human brain tissue.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.